The introduction of inhibitors of the cyclic GMP phosphodiesterase (PDE) 5 into clinical urology is ... as safe and well-tolerated orally active drugs for the treatment of erectile dysfunction ...

Medically reviewed by Lindsay Cook, PharmD Viagra (sildenafil) is an oral drug used to treat erectile dysfunction (ED) that ...

A new study reports that mirodenafil, a newly developed oral phosphodiesterase type 5 (PDE5 ... the currently available PDE5 inhibitors cease treatment, as the drugs might not provide optimal ...

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug ... and effective phosphodiesterase type 5 (PDE5) inhibitors ...

The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer healthcare business, Opella. Opella had launched the actual use trial (AUT ...

Erectile Dysfunction Drugs Market 2025 The global market is driven by factors such as an Increase in the prevalence of erectile dysfunction ...

French pharma major Sanofi’s consumer healthcare business, Opella, has announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to ...

Cialis is the only PDE-5 inhibitor treatment that offers men a choice when it ... mononitrate which are often prescribed for chest pain; or with recreational drugs called poppers like amyl or butyl ...

May potentiate drugs primarily metabolized by CYP3A within ... dabigatran, edoxaban), PDE-5 inhibitors (eg, sildenafil, tadalafil, vardenafil). Concomitant with tadalafil (to treat PAH): not ...